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The Modulation of Aromatase and Estrogen Receptor
Alpha in Cultured Human Dermal Papilla Cells by
Dexamethasone: A Novel Mechanism for Selective
Action of Estrogen via Estrogen Receptor Beta?
M. Julie Thornton1, Louisa D. Nelson1, Anthony H. Taylor2, M. Pattie Birch4, Ian Laing3
and Andrew G. Messenger4
Steroid hormones have important modulatory effects on the hair follicle, but the mechanisms by which they
regulate human hair growth are still poorly understood. It is now clear that there are two distinct estrogen
receptors (estrogen receptor alpha (ERa) and estrogen receptor beta (ERb)) that bind 17b-estradiol. Since the
follicular dermal papilla is known to control hair growth, and steroid hormones regulate receptor and
aromatase expression in other tissues, we tested the hypothesis that steroid hormones would similarly
modulate estrogen receptor and/or aromatase expression in cultured dermal papilla cells derived from human
hair follicles. Primary cultures of non-balding occipital and frontal scalp and beard dermal papilla cells (n¼ 10)
were established. Immunocytochemical studies showed the expression of ERa in both the cytoplasm and
nucleus, whereas ERb was confined to the nuclei. The cells derived from occipital scalp were also incubated for
24 hours with 10 nM of either 17b-estradiol, estrone, testosterone, 5a-dihydrotestosterone, 5a-androstane-3a,
17b-diol, 5a-androstane-3b, 17b-diol, or 100 nM tamoxifen or dexamethasone in phenol red-free, serum-free
medium to measure the steady-state levels of ERa, ERb, and aromatase mRNA by semiquantitative reverse
transcriptase-PCR. Although androgens and estrogens did not alter ERa mRNA levels, treatment with
dexamethasone significantly reduced ERa levels to 38% of the untreated control. By contrast, ERb mRNA levels
were unaffected by any steroid treatment. Furthermore, dexamethasone significantly stimulated the expression
of aromatase mRNA approximately 9-fold. Aromatase activity, assayed by the tritiated water method, was
stimulated in both frontal scalp and beard dermal papilla cell cultures by dexamethasone. These observations
provide evidence for a glucocorticoid-dependent mechanism whereby the selective action of estradiol via ERb
may be promoted. Additionally, upregulation of aromatase combined with downregulation of ERa provides a
basis for selective action of estradiol produced locally by autocrine or paracrine mechanisms.
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INTRODUCTION
Hair follicles have a built in rhythm of activity that results in
the periodic growth of new hairs and the moulting of old
ones. Steroid hormones, including androgens (Randall et al.,
2000), estrogens (Thornton, 2002), and glucocorticoids (Paus
et al., 1994) influence that rhythm. Although there has been
much focus on androgen-regulated hair growth in recent
years, studies on the role of other steroids and their
mechanism of action in the hair follicle have been relatively
limited.
It has been recognized for more than 70 years that ovarian
hormones inhibit mammalian hair growth (Dawson, 1933;
Johnson, 1958; Hale and Ebling, 1975). Topical 17b-estradiol
applied to mouse skin causes an inhibition of hair growth (Oh
and Smart, 1996; Smart et al., 1999; Chanda et al., 2000),
while administration of an antiestrogen stimulates the telogen
follicle into anagen earlier than seen in the corresponding
control mice (Oh and Smart 1996; Chanda et al., 2000). More
recent studies have shown that topical 17b-estradiol en-
hances chemotherapy-induced hair loss in mice by forcing
hair follicles into the dystrophic catagen response pathway to
hair follicle damage (Ohnemus et al., 2004). Furthermore,
normal murine skin treated with 17b-estradiol displays a
significantly accelerated catagen wave progression (Ohnemus
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et al., 2005), suggesting that 17b-estradiol has a direct
inductive activity on catagen initiation.
In humans, the effects of estrogens seem more complex
whereby estrogen prolongs the anagen phase of the hair
follicle, as shown in plucked hairs from pregnant women
who demonstrated an increased number of hairs in anagen
compared to non-pregnant controls (Lynfield, 1960). An
inhibitory effect of 17b-estradiol has also been demonstarted
on human, non-balding scalp hair growth in vitro (Kondo
et al., 1990; Nelson et al., 2003), in parallel to the in vivo
effects described in rodents. However, in a comparable organ
culture system 17b-estradiol stimulates hair shaft elongation
in fronto-temporal male hair follicles (Conrad and Paus,
2004; Conrad et al., 2004).
Autoradiography of rat skin has identified the dermal
papilla, which plays a pivotal role in the regulation of hair
growth and hair follicle cycling, as the follicular target for
estrogens (Stumpf et al., 1974; Bidmon et al., 1990).
Recently, estrogen receptors have been localized to the
dermal papilla of human occipital scalp hair follicles both in
vivo and in vitro (Lachgar et al., 1999; Thornton et al.,
2003a, b, c). There are two distinct estrogen receptors,
estrogen receptor alpha (ERa) and estrogen receptor beta
(ERb) (Kuiper et al., 1996; Mosselman et al., 1996) that bind
17b-estradiol with a similar affinity (Kuiper et al., 1997) and
in human skin, ERb appears to be the predominant estrogen
receptor (Brandenberger et al., 1997; Pelletier, 2000;
Thornton et al., 2003a, b; Pelletier and Ren, 2004).
The production of estrogens from androgen precursors via
the aromatase cytochrome P450 enzyme complex, at the
local tissue level, is of the utmost importance in many tissues
(Simpson, 1998), including the hair follicle. Plucked human
hair follicles demonstrate aromatase activity in culture
(Schweikert et al., 1975), while a comparison of scalp
biopsies from men and women with androgenetic alopecia
revealed aromatase levels to be higher in hair follicles from
occipital scalp when compared to those from the frontal scalp
(Sawaya and Price, 1997). Furthermore, the same study found
that aromatase levels were approximately six times higher in
the frontal hair follicles of women when compared to men.
Recent studies using reverse transcriptase (RT)-PCR have
demonstrated that both cultured dermal papilla cells and
outer root sheath keratinocytes express mRNA for aromatase
(Lachgar et al., 1999).
It is also evident that other steroid hormones have
opposing effects to estrogens in some target tissues. For
example androgens and estrogens have opposing effects in
the prostate gland (Jarred et al., 2000). Likewise glucocorti-
coids and estrogens have opposing effects in endometrium
(Rhen et al., 2003) and in bone (Lukert et al., 1992). Since the
levels of estrogen receptor expression and aromatase expres-
sion can be modulated by steroid hormones in other tissues
(Stillman et al., 1990, 1991; Simerly and Young, 1991;
Jaubert et al., 1995; Bethea et al., 1996), we hypothesized
that similar inter-dependent mechanisms would be important
in the human hair follicle.
Although previous studies demonstrated that cultured
dermal papilla cells express an estrogen receptor, it was not
determined whether this was ERa or ERb (Lachgar et al., 1999).
Therefore, the first aim of this study was to determine whether
dermal papilla cells from human scalp follicles express mRNA
and protein for ERa and ERb in culture. The second aim was
to establish whether the expression of ERa, ERb, or aromatase
is modulated in vitro, by other steroid hormones, including
androgens, estrogens, and glucocorticoids.
RESULTS
Human non-balding scalp dermal papilla cells express mRNA
for ERa, ERb, and aromatase in vitro
Messenger RNA for ERa, ERb, and aromatase were expressed
in all five different primary cell cultures of dermal papilla
cells derived from human female non-balding occipital scalp
hair follicles (Figure 1). Although the ratio of ERa:ERb mRNA
levels varied from cell line to cell line, the average ratio was
approximately 2:1 (data not shown). There was no significant
difference in the expression of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) between any of the cell lines (data
not shown).
Androgens and estrogens do not alter the expression of ERa,
ERb, and aromatase mRNA, but glucocorticoid downregulates
ERa and upregulates aromatase mRNA in cultured human
dermal papilla cells
The estrogens 17b-estradiol and estrone; the androgens
testosterone, 5a-dihydrotestosterone (DHT), 5a-androstane-
3a, 17b-diol, and 5a-androstane-3b, 17b-diol; and the
selective estrogen receptor modulator, tamoxifen, had no
significant effect on the expression of ERa, ERb, or aromatase
mRNA in cultured dermal papilla cells (Figures 2–4).
However, the synthetic glucocorticoid, dexamethasone sig-
nificantly (P¼0.0097) downregulated the expression of ERa
mRNA in cultured human dermal papilla cells (Figure 2),
although it had no significant effect on the expression of ERb
mRNA (Figure 3). The ratio of ERa mRNA to ERb mRNA
levels did not normalize the effect that dexamethasone might
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Figure 1. Human dermal papilla cells express mRNA for ERa, ERb, and
aromatase in culture. Ethidium bromide-stained RT-PCR gels showing the
expression of ERa, ERb, aromatase, and GAPDH mRNA from cultured dermal
papilla cells derived from five different patients: Numbers 1–5 denote the five
different dermal papilla cell cultures, lane 6 (þ ) is a human myometrium
sample that acted as a positive control for ERa and GAPDH or a human ovary
sample that acted as a positive control for ERb and aromatase. The final lane is
a RT control for the assay. Size markers for the 100 bp DNA marker (L) are
shown to the left of the figure.
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have had independently on the expression of these proteins
and the ratio changed significantly from 2.1370.62 in the
untreated cultures to 0.7470.39 in the dexamethasone-
treated cultures. Furthermore, dexamethasone significantly
(P¼0.048) upregulated the expression of aromatase mRNA
in the same cells (Figure 4). Independent of any steroid
treatment, GAPDH did not show any significant difference in
expression (data not shown).
Dexamethasone upregulates aromatase activity in cultured
dermal papilla cells
Basal expression of aromatase enzyme activity could not be
detected in five different dermal papilla cell cultures (Table 1)
and incubation with either testosterone or 5a-DHT
(1–100 nmol/l) for 48 hours failed to increase aromatase
activity above the assay lower threshold limit. However, all
five cell cultures demonstrated an increase in aromatase
activity following treatment with dexamethasone for 18 hours
to measurable values (Table 1). As the aromatase activities in
frontal scalp and beard overlapped (423–689 compared to
181–865 pmol/mg protein/hour, respectively), no apparent
difference in activity between different anatomical sites could
be supported.
Human non-balding scalp dermal papilla cells express ERa and
ERb protein in vitro
ERa and ERb were both expressed in cultured dermal papilla
cells derived from female human non-balding occipital scalp
hair follicles. Immunohistochemical localization of ERb
clearly demonstrated that this receptor was exclusively
confined to the cell nuclei (Figure 5c). In contrast, ERa was
distributed throughout the cell and was expressed in both the
nucleus and cytoplasm of cultured dermal papilla cells
(Figure 5b). Every cell expressed both estrogen receptors
through several passages in culture (data not shown).
DISCUSSION
To help us understand the steroid hormone interactions that
might occur in the hair follicle we sought to confirm the
expression of the two estrogen receptors, ERa and ERb, in
cultured human scalp dermal papilla cell lines derived from
1
2
3
4
5
a c e g i +a b
Ct
rl E1 E2 Ta
m
Ta
m
/E
2 T
DH
T
Di
ol 
1
Di
ol 
2
De
x
0.0
0.5
1.0
1.5
2.0
R
el
at
iv
e 
ER
 
m
R
N
A 
le
ve
ls
**
b d f h j
Figure 2. ERa mRNA expression in cultured human dermal papilla cells is
reduced by dexamethasone, but not by androgens and estrogens.
(a) Ethidium bromide-stained RT-PCR gels showing changes in the levels of
ERa mRNA levels in untreated cultured human dermal papilla cell lines (Ctrl,
lane a) or when treated for 24 hours with either, 10 nM estrone (E1, lane b),
10 nM 17b-estradiol (E2, lane c), 100 nM tamoxifen (Tam, lane d) a
combination of 100 nM tamoxifen, and 10 nM E2 (Tam/E2, lane e), 10 nM
testosterone (T, lane f), 10 nM 5a-DHT (lane g), 10 nM 5a-androstane-3a,
17b-diol (Diol 1, lane h), 10 nM 5a-androstane-3b, 17b-diol (Diol 2, lane i),
or 100 nM dexamethasone (Dex, lane j). Numbers to the right indicate the
individual cell lines. (b) Graphical depiction of grouped data from (a) after
correction for individual GAPDH levels (data not shown). Messenger RNA
levels are presented as the mean7SEM and analyzed against the untreated
controls. (*Po0.05; Student’s t-test with Welch’s correction; n¼5).
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Figure 3. Androgens, estrogens, and glucocorticoids have no effect on the
expression of ERb mRNA in cultured human dermal papilla cells.
(a) Ethidium bromide-stained RT-PCR gels showing changes in the levels of
ERb mRNA levels in untreated cultured human dermal papilla cell lines (Ctrl,
lane a) or when treated for 24 hours with either, 10 nM estrone (E1, lane b),
10 nM 17b-estradiol (E2, lane c), 100 nM tamoxifen (Tam, lane d) a
combination of 100 nM tamoxifen and 10 nM E2 (Tam/E2, lane e), 10 nM
testosterone (T, lane f), 10 nM 5a-DHT (lane g), 10 nM 5a-androstane-3a,
17b-diol (Diol 1, lane h), 10 nM 5a-androstane-3b, 17b-diol (Diol 2, lane i),
or 100 nM dexamethasone (Dex, lane j). Numbers to the right indicate the
individual cell lines. (b) Graphical depiction of grouped data from (a) after
correction for individual GAPDH levels. Messenger RNA levels are presented
as the mean7SEM and analyzed against the untreated controls. (Data are not
significantly different; Student’s t-test with Welch’s correction; n¼ 5).
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Figure 4. Dexamethasone upregulates the expression of aromatase mRNA in
cultured human dermal papilla cells, but androgens and estrogens have no
effect. (a) Ethidium bromide-stained RT-PCR gels showing changes in the
levels of aromatase mRNA levels in untreated cultured human dermal papilla
cell lines (Ctrl, lane a) or when treated for 24 hours with either, 10 nM estrone
(E1, lane b), 10 nM 17b-estradiol (E2, lane c), 100 nM tamoxifen (Tam, lane d) a
combination of 100 nM tamoxifen and 10 nM E2 (Tam/E2, lane e), 10 nM
testosterone (T, lane f), 10 nM 5a-DHT (lane g), 10 nM 5a-androstane-3a,
17b-diol (Diol 1, lane h), 10 nM 5a-androstane-3b, 17b-diol (Diol 2, lane i),
or 100 nM dexamethasone (Dex, lane j). Numbers to the right indicate the
individual cell lines. (b) Graphical depiction of grouped data from (a) after
correction for individual GAPDH levels (data not shown). Messenger RNA
levels are presented as the mean7SEM and analyzed against the untreated
controls. (*Po0.05; Student’s t-test with Welch’s correction; n¼5).
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human non-balding scalp hair follicles by RT-PCR and
immunohistochemistry (Figures 1 and 5). The present study
clarifies that human dermal papilla cells express both
estrogen receptor subtypes in vitro and thus cultured human
dermal papilla cells provide a suitable model to study the role
of estrogens in the control of hair growth. To test this idea we
examined the ability of steroid hormones to affect estrogen
receptor mRNA expression and P450 aromatase mRNA
expression and activity, since aromatase converts local
androgens to estrogens (Baker, 2002) and so could provide
a putative mechanism for hair growth control.
There is growing evidence that in addition to 17b-
estradiol, androgen metabolites can also interact with either
ERa or ERb. For example, D5-androstene-3b, 17b-diol, a
metabolite of dehydroepiandrosterone has been reported to
bind to ERa (Maggiolini et al., 1999). Likewise, a major
metabolite of 5a-DHT, 5a-androstane-3b, 17b-diol, formed
by the action of 3b-hydroxysteroid dehydrogenase (see
Figure 6), can interact with both ERa and ERb, whereas its
isomer 5a-androstane-3a, 17b-diol has weak androgenic
effects (reviewed by Weihua et al., 2003). Collectively, this
suggests that the presence of ERa and ERb in human dermal
papilla cells may provide more than one function in
modulating the hair follicle depending upon (1) the metabo-
lite that activates the receptor, (2) which receptor is activated,
(3) which series of co-activators or co-repressors are involved
and (4) whether receptor hetero- or homo-dimers are formed
on the estrogen response element (ERE) or interact with other
nuclear trans-activating factors. Therefore, the ratio of ERa to
ERb in follicular dermal papilla cells may be important.
In other tissues the levels of ERa to ERb are regulated at the
cell or tissue level. For example, estrogens upregulate ERa in
Table 1. Dexamethasone upregulates aromatase activity in cultured dermal papilla cells
Site Sex
Aromatase activity
control (pmol/mg/
protein/hour)
Aromatase activity
testosterone
(1–100 nmol/l)
(pmol/mg/protein/
hour)
Aromatase activity
5a-DHT
(1–100 nmol/l)
(pmol/mg/protein/
hour)
Aromatase activity
dexamethasone
(250 nmol/l) (pmol/
mg/protein/hour)
Frontal scalp F ND ND ND 423
Frontal scalp M ND ND ND 689
Beard M ND ND ND 181
Beard M ND ND ND 583
Beard M ND ND ND 865
F: female; M: male; ND: not detected.
a b
c
50 m 50 m
50 m
Figure 5. Human dermal papilla cells express ERa and ERb protein in
culture. Immunohistochemical localization of ERa and ERb in cultured
dermal papilla cells derived from human non-balding scalp hair follicles.
Bound antibody was visualized with diaminobenzadine. (a) Negative control,
where the primary antibody was omitted. (b) Expression of ERa seen
distributed throughout the cytoplasm. (c) Expression of ERb, which was
confined specifically to the nucleus.
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Figure 6. The active androgens are testosterone and 5a-DHT. Both bind
to the androgen receptor with a high affinity and the active estrogen is
17b-estradiol, which binds to both estrogen receptors with similar affinity.
However, humans also secrete large amounts of the precursor steroids
dihydroepiandrosterone sulfate and androstenedione from the adrenal cortex,
which can be converted to the more potent androgens and estrogens by the
appropriate enzymes. DHT may be further metabolized by 3b-hydroxysteroid
dehydrogenase to 5a-androstane-3b, 17b-diol, which can interact with both
ERa and ERb, or by 3a-hydroxysteroid dehydrogenase to its isomer
5a-androstane-3a, 17b-diol which has weak androgenic effects. A number
of different 17b-hydroxysteroid dehydrogenases regulate different oxidative
and reductive pathways.
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prostatic stroma without altering ERb levels (Prins et al.,
1998) and in cancer cell lines 17b-estradiol causes a decrease
in ERa protein expression (Read et al., 1989; Taylor et al.,
2001). Likewise androgens have also been reported to alter
the ratio of ERa to ERb in the mammary gland (Dimitrakakis
et al., 2003). These data suggest that estrogen receptor
expression might also be regulated in the dermal papilla cell.
However, we found that the estrogens 17b-estradiol, estrone,
the selective estrogen receptor modulator, tamoxifen, and the
androgens, testosterone, DHT, 5a-androstane-3a, 17b-diol,
and 5 a-androstane-3b, 17b-diol had no effect on the
expression of either ERa or ERb mRNA from cultured dermal
papilla cells derived from female non-balding occipital scalp
follicles, suggesting that other mechanisms must exist to
control the levels of the receptors. However, the synthetic
glucocorticoid dexamethasone specifically downregulated
the expression of ERa mRNA (Figure 2), with no change in
ERbmRNA expression (Figure 3). The alteration in the ratio of
ERa to ERb in cultured dermal papilla cells could therefore
promote estrogen signalling via ERb, in preference to ERa.
Glucocorticoids have been reported to have a modulatory
effect on the hair follicle (Stenzel-Poore et al., 1992;
Ozerdem et al., 2000), and dexamethasone can induce
catagen in the murine hair follicle (Paus et al., 1994).
Furthermore, the overexpression of the glucocorticoid re-
ceptor in transgenic mice results in underdeveloped dysplas-
tic hair follicles (Pe´rez et al., 2001). In cultured dermal
papilla cells, hydrocortisone decreases cell proliferation
(Katsuoka et al., 1987), while dexamethasone increases the
production of IGFBP-3, inhibiting local IGF-1 availability
(Hembree et al., 1996). These data suggest that glucocorti-
coids may have a definitive role in hair follicle growth.
However, our data suggest that one of the actions of
glucocorticoids is to bias the estrogen signalling pathway
towards an ERb-dependent pathway, which may be impor-
tant since estrogens also regulate hair growth. This opens the
possibility that there is a subset of estrogen-regulated genes in
the dermal papilla cell that are specifically targeted through a
glucocorticoid/estrogen paracrine interaction.
It is now becoming apparent that cross-talk between
steroid receptors is important in cells which express
combinations of steroid receptors e.g. ERa, ERb, androgen
receptor, glucocorticoid receptor, and progesterone receptor
(Kraus et al., 1995; Tuohimaa et al., 1996; Esposito et al.,
2002). Whether the modulatory effects on ERa seen in this
study are due to the direct effects of dexamethasone or to
alterations in the levels of glucocorticoid receptor protein
through a feedback mechanism whereby ERa controls
glucocorticoid receptor expression remains to be established.
However, since the hair follicle has been shown to express all
of these receptors (Randall et al., 1992; Karstila et al., 1994;
Wallace and Smoller, 1998; Thornton et al., 2003a),
signalling via steroid receptors in the hair follicle is likely to
be even more complex than described herein. These are
subjects for further research.
The expression of aromatase mRNA in cultured dermal
papilla cells derived from female human non-balding
occipital scalp hair follicles was also confirmed using RT-
PCR (Figures 1 and 4), supporting a previous study by Lachgar
et al. (1999). In the present study, some dermal papilla cell
cultures expressed high levels of mRNA for aromatase that
were comparable to those found in the human ovary.
However, measurement of aromatase enzyme activity in-
dicated low levels of basal expression in the cultured dermal
papilla cells derived from both scalp and beard hair follicles
(Table 2).
Although both androgens and estrogens have been shown
to increase aromatase activity in other tissues (Sasano and
Harada, 1998; Yanase et al., 2003), there was no significant
change in aromatase mRNA expression in cultured dermal
papilla cells in this study (Figure 4). Furthermore, neither
testosterone nor 5a-DHT increased basal levels of aromatase
enzyme activity in cultured dermal papilla cells derived from
either scalp or beard hair follicles (Table 2).
Glucocorticoids have also been shown to induce aroma-
tase expression in other human cells (Jakob et al., 1995;
Tanaka et al., 1996; McTernan et al., 2002; Yanase et al.,
2003) and in this study the incubation of cultured dermal
papilla cells with dexamethasone resulted in a significant
increase in aromatase mRNA by almost 10-fold (Figure 4).
Measurement of aromatase enzyme activity in cultured
dermal papilla cells derived from both scalp and beard hair
Table 2. Primer design and expected amplicons sizes
mRNA target
GenBank
accession No. Primers
Expected
size (bp) References
ERa m12674 50-CAGACATGAGAGCTGCCAAC-30 sense 381 Taylor et al. (2001)
50-CCAAGAGCAAGTTAGGAGCA-30 antisense
ERb x99101 50-TCCCTGGTGTGAAGCAAGATC-30 sense 279 Mesiano et al. (2002)
50-CGCCGGTTTTTATCGATTGT-30 antisense
P450 aromatase m22246 50-CAAGGTTATTTTGATGCATGG-30 sense 485 Catalano et al. (2003)
50-TTCTAAGGTTTGCGCATGA-30 antisense
GAPDH x01677 50-AGAACATCATCCCTGCCTC-30 sense 347 Hall et al. (1998)
50-GCCAAATTCGTTGTCATACC-30 antisense
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follicles was up regulated following incubation with dexa-
methasone (Table 1), supporting the upregulation of the
expression of aromatase mRNA in the quantitative RT-PCR
studies.
These data demonstrate that the expression of aromatase
in the hair follicle is regulated at the local level and within the
dermal papilla cell. Since both the dermal papilla and
surrounding epithelial cells express estrogen receptors
(Thornton et al., 2003a, b), these locally produced estrogens
may act in either an autocrine or paracrine manner to control
either cell growth or differentiation. Understanding the mecha-
nisms involved could have significant clinical implications
in the treatment of hair disorders.
Combined with the downregulation of ERa by dexametha-
sone (Figure 2), an increase in estrogen production suggests a
selective mechanism exists in human dermal papilla cells for
triggering ERb-mediated transcriptional pathways, or differ-
entially triggering transcription activation or repression
pathways by ERb.
In summary, this study has demonstrated that dermal
papilla cells derived from female human non-balding
occipital scalp hair follicles express mRNA for ERa, ERb
and aromatase in culture. Furthermore, the levels of ERa
mRNA, aromatase mRNA, and enzyme activity are modu-
lated by the glucocorticoid receptor agonist dexamethasone.
The upregulation of aromatase and downregulation of ERa by
dexamethasone provides a novel mechanism for selective
action of 17b-estradiol via ERb in the human hair follicle.
Further studies comparing dermal papilla cells cultured from
androgen-dependent hair follicles will enhance our under-
standing of the interaction between estrogens, androgens,
and glucocorticoids in the human hair follicle and may
provide important clinical applications for the prevention and
treatment of disorders of hair growth.
MATERIALS AND METHODS
Steroids
17b-estradiol, estrone, testosterone, 5a-DHT, 5a-androstane-3a,
17b-diol, 5a-androstane-3b, 17b-diol, tamoxifen, and dexametha-
sone were purchased from Sigma (Poole, Dorset, UK). [1b3H]-
androstenedione (specific activity 23 Ci/mmol) was obtained from
Amersham International plc (Amersham, Bucks, UK).
Antibodies
The monoclonal mouse antibovine ERa (05-394) antibody directed
against SDS-solubilized calf uterus ERa, and polyclonal rabbit anti-
rat ERb (06-629) antibody developed against the N-terminal region
of the human ERb sequence were purchased from Upstate
Biotechnology (Lake Placid, NY).
Cell culture
Human skin samples were obtained from healthy individuals with
full consent and ethical approval and conformed to the guidelines
contained within the Declaration of Helsinki Principles. Samples
were kept in DMEM (Biowest, Leicestershire, UK) or phosphate-
buffered saline (PBS) and stored at 41C until collection. The samples
were collected no more than 2 hours after surgery and transported to
the laboratory. Microdissection procedures were carried out
according to the methods of Messenger (1984). Dermal papillae
from four or five follicles were transferred to a 35 mm dish
containing DMEM supplemented with penicillin (100 U/ml), strep-
tomycin (100 mg/ml), glutamine (2 mmol/ml), amphotericin B (2.5mg/
ml), (Flow Laboratories Ltd, Surrey, UK), and 20% fetal bovine serum
(Globefarm Ltd, Surrey, UK). Once cells from the dermal papilla
explants were established, the media was supplemented with 10%
fetal bovine serum rather than 20%. All cell lines were maintained in
culture at 371C in a 95% air, 5% CO2-humidified incubator.
Effect of androgen, estrogen, and glucocorticoid on the
expression of ERa, ERb, and aromatase in cultured dermal
papilla cells
Incubation of dermal papilla cells with steroid hormones
and RNA isolation. Cells were seeded into 25 cm2 flasks in normal
growth medium and grown to subconfluence. The medium was
removed and the cells washed twice with PBS. The medium was
replaced with serum-free phenol red-deficient DMEM and incubated
for 24 hours. The medium was replaced with fresh serum-free,
phenol-red free medium containing either 17b-estradiol (10 nM),
estrone (10 nM), testosterone (10 nM), 5a-DHT (10 nM), 5a-andro-
stane-3a, 17b-diol (10 nM), 5a-androstane-3b, 17b-diol (10 nM),
tamoxifen (100 nM), dexamethasone (100 nM), or vehicle control
(0.001% absolute alcohol). After 24 hours the medium was removed
and total cellular RNA prepared using the Genelute mammalian total
RNA kit (Sigma, UK) according to the manufacturer’s instructions
and the eluted RNA stored at 801C. The concentration, purity, and
integrity of the resulting total RNA was determined spectrophoto-
metrically before the presence of mRNA for ERa, ERb, aromatase,
and GAPDH was determined using RT-PCR.
Reverse transcription and PCR. First-strand synthesis was
performed on 1mg of total cellular RNA using AMV-RT (Promega
Corp., Madison, WI) according to the manufacturer’s instructions in
the presence of 25 U of RNase inhibitor (RNasin; Promega Corp.)
0.4 mM deoxyribonucleotide triphosphate (dNTP) mixture and 2.8 mM
anchored dT primer (Sigma-Aldrich, Poole, UK) for 1 hour at 421C,
followed by 2 minutes at 951C to denature the RT enzyme.
Amplification of GAPDH and ERa was performed in a Genius
thermal cycler (Techne Corp., Duxford, UK) using 1 ml of cDNA,
whereas ERb and aromatase were amplified using 2 ml cDNA.
Reactions included 5ml of 10AJ Buffer (450 mM Tris-HCl (pH 8.8));
110 mM NH4SO4; 45 mM MgCl2; 2 mM of each deoxyribonucleotide
triphosphate; 1.1 mg/ml acetylated BSA (Roche Diagnostics Ltd,
Lewes, UK; 110 mM b-mercaptoethanol; 4.4 mM EDTA), 10 pmol of
GAPDH-, ERa- and ERb-specific primers, and 1 pmol of aromatase-
specific primers combined with 1.0 U of Taq polymerase (Promega
Corp.) diluted in 1AJ Buffer. The thermal cycler conditions for
GAPDH were an initial denaturation step at 951C for 2 minutes,
followed by 35 cycles of 951C for 45 seconds, 601C for 1 minute,
721C for 1 minute with a final extension time of 10 minutes at 721C.
The absence of genomic DNA was confirmed using samples where
the AMV-RT enzyme had been omitted. Optimal cycle conditions
for ERa were 941C, for 30 seconds, 601C for 30 seconds, 681C for
1 minute, for an initial 10 cycles followed by another 25 cycles with
increased extension times of 5 secconds/cycle followed by a final
extension for 5 minutes at 681C. The amplification conditions for ERb
were the same as those for ERa with the exception that 40 total
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cycles were required. Aromatase was amplified using 1 pmol of each
primer with optimized cycle conditions of 941C for 1 minute, 601C
for 1 minute, and 721C for 2 minutes for 40 cycles followed by a final
extension for 10 minutes at 721C. The amplification profiles for each
gene were all within the linear range of detection (data not shown).
After PCR, the reaction mixtures were separated through 3% TAE-
agarose gels impregnated with ethidium bromide at B5 V/cm for
1 hour for UV visualization and images capture on a Gene Genius
gel documentation and analysis system (Syngene, Cambridge, UK).
Deoxyribonucleotide primers were obtained from Sigma-Genosys
(Pampisford, Cambridgeshire, UK) and purified by gel electrophor-
esis prior to use. The mRNA specific primer sets are described in
Table 2. The expected sizes for the amplicons were 381 bp for ERa,
279 bp for ERb, 485 bp for aromatase, and 347 bp for GAPDH. The
levels of the GAPDH housekeeping gene was used to evaluate any
variation in the mRNA content and cDNA synthesis in the different
preparations and were not found to differ between any of the steroid
treatments. No PCR products were detected when the RT was
omitted (data not shown).
Assay of aromatase activity
Aromatase activity was measured using a tritiated water assay
(Lephart and Simpson, 1991). Briefly dermal papilla cells cultured to
confluence in 24 well plates were washed three times with PBS and
incubated with 1 ml fresh serum-free medium supplemented with
either testosterone or 5a-DHT (1–100 nmol/l) for up to 48 hours, or
dexamethasone (250 nmol/l) for 18 hours. After washing the cells
three more times with PBS, 0.5mCi [1b3H]-androstenedione in fresh
medium was added and cells incubated for 2 hours at 371C. Cell-
conditioned medium was extracted by sequential treatment with
chloroform and activated charcoal to remove unmetabolized steroids
and metabolized radiolabelled products in the aqueous phase were
measured by scintillation counting. The cell layer was dissolved in
Triton X and the protein measured using the Lowry assay method
(Lowry et al., 1951). Results are expressed as mean pmol/mg cell
protein/hour. All experiments were performed on triplicate wells.
Localization of ERa and ERb in cultured dermal papilla cells
using immunohistochemistry
Dermal papilla cells were incubated on sterile frosted microscope
slides in normal growth medium and incubated at 371C for
24–48 hours to allow cell attachment before fixation in ice-cold
acetone for 10 minutes. Endogenous peroxidase activity was
quenched using hydrogen peroxide (6% v/v; in methanol) for
10 minutes. After immersion in distilled water and PBS-Tween 20
(0.05% v/v), cells were blocked for 1 hour with PBS containing 3%
BSA. Cells were further blocked with normal horse serum (10%) for
1 hour. The sections were further blocked with avidin–biotin
blocking solution according to the manufacturer’s instructions (cat
no. SP-2001, Vector Laboratories, Peterborough, UK). Excess liquid
was removed from around the section and the slide was incubated
with anti-ERa (1:50) or anti-ERb (1:50) in a humidified chamber at
41C for 18 hours. After washing in PBS-Tween 20, sections were
incubated with biotinylated horse anti-rabbit/anti-mouse (Vector
Elite kit, Vector Laboratories, Peterborough, England) diluted 1:50 in
PBS for 30 minutes. Following a further wash in PBS-Tween 20
(3 10 minutes), the sections were incubated with horseradish-
peroxidase avidin–biotin complex (Vector Elite kit, Vector Laboratories)
for 30 minutes. After an additional wash in PBS-Tween 20
(3 10 minutes), bound antibodies were visualized with 0.05%
diaminobenzidine in 0.05 M Tris-HCl, pH 7.4, and 0.01% hydrogen
peroxide, according to the supplier’s instructions (Vector Labo-
ratories). Cells were then washed in running tap water for 5 minutes,
submerged in 16 mM CuSO4/123 mM NaCl solution (5 minutes),
rewashed in tap water, counterstained with Harris’ hematoxylin,
dehydrated through graded alcohol, cleared with histoclear, and
permanently mounted using histomount mounting medium (BDH,
Poole, Dorset, UK). Specificity of immunostaining was confirmed
using several control sections produced by omission of the primary
antibody. Positive control cells for the expression of ERa and ERb
(data not shown) included the MCF(7) breast cancer cell line and the
human colon cancer cell lines HCT116 and HT29 (kindly donated
by Dr R. Phillips, Tom Connors Cancer Research Unit, Bradford,
UK). Positive control tissue included human ovary for expression of
ERa and human prostate for expression of ERb.
Statistical analysis
Data from the RT-PCR method were corrected for GAPDH levels,
and normalized to the mean control ratio (Lang and Heeg, 1998) and
are presented as means7SEM relative to the untreated control
cultures. Comparison of mean differences was performed using
unpaired Student’s t-test with Welch’s correction for samples with
unequal variances on the log-transformed ratios. A probability value
of o0.05 was considered significant. Statistical values were
obtained using GraphPad InStat version 3.01 for Windows 95/NT,
GraphPad Software, San Diego, CA, www.graphpad.com.
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